相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin G. Van Meir et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents
T. Sanchez-Perez et al.
CELL DEATH AND DIFFERENTIATION (2010)
Review: On TRAIL for malignant glioma therapy?
J. M. A. Kuijlen et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2010)
New insights into apoptosis signaling by Apo2L/TRAIL
F. Gonzalvez et al.
ONCOGENE (2010)
Enhancing the apoptotic and therapeutic effects of HDAC inhibitors
Ailsa J. Frew et al.
CANCER LETTERS (2009)
The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation
Daniela Carlisi et al.
EUROPEAN JOURNAL OF CANCER (2009)
Identification of a novel pro-apopotic function of NF-κB in the DNA damage response
Sabine Karl et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL
Dolly G. Aguilera et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Enhanced Fas-associated death domain recruitment by histone deacetylase inhibitors is critical for the sensitization of chronic lymphocytic leukemia cells to TRAIL-induced apoptosis
Satoshi Inoue et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Epigenetics in cancer: Targeting chromatin modifications
Leigh Ellis et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Histone deacetylase inhibitors cooperate with IFN-γ to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8
S. Haecker et al.
ONCOGENE (2009)
DNER, an Epigenetically Modulated Gene, Regulates Glioblastoma-Derived Neurosphere Cell Differentiation and Tumor Propagation
Peng Sun et al.
STEM CELLS (2009)
Phosphatidylinostol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis
Daniela Opel et al.
CANCER RESEARCH (2008)
Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-κB, and glucose regulation
Svetlana Kotliarova et al.
CANCER RESEARCH (2008)
Modulation of TRAIL-induced apoptosis by HDAC inhibitors
Simone Fulda
CURRENT CANCER DRUG TARGETS (2008)
Forkhead box-O transcription factor: critical conductors of cancer's fate
Carl Weidinger et al.
ENDOCRINE-RELATED CANCER (2008)
Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
Avi Ashkenazi
NATURE REVIEWS DRUG DISCOVERY (2008)
IAP-targeted therapies for cancer
E. C. LaCasse et al.
ONCOGENE (2008)
Bcl-2-regulated apoptosis: mechanism and therapeutic potential
Jerry M. Adams et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
c-Myc primed mitochondria determine cellular sensitivity to TRAIL-induced apoptosis
Anni I. Nieminen et al.
EMBO JOURNAL (2007)
Mitochondrial membrane permeabilization in cell death
Guido Kroemer et al.
PHYSIOLOGICAL REVIEWS (2007)
The ins and outs of MYC regulation by posttranslational mechanisms
Jorg Vervoorts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275
LY Eyüpoglu et al.
MOLECULAR CANCER THERAPEUTICS (2006)
HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL
A Pathil et al.
HEPATOLOGY (2006)
E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIPshort
C Salon et al.
CELL DEATH AND DIFFERENTIATION (2006)
The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases
MV Simonini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP
EH Kim et al.
ONCOGENE (2005)
HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma
TR Singh et al.
ONCOGENE (2005)
Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP
K Watanabe et al.
CELL DEATH AND DIFFERENTIATION (2005)
Cotreatment with histone deacetylase inhibitor LAQ824 enhances apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells
F Guo et al.
CANCER RESEARCH (2004)
The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP
C Skurk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity
MS Ricci et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway
Y Wang et al.
CANCER CELL (2004)
Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein
JL Aron et al.
BLOOD (2003)
NF-κB signals induce the expression of c-FLIP
O Micheau et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis
A Hernandez et al.
SURGERY (2001)
The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways
T Kataoka et al.
CURRENT BIOLOGY (2000)
Regulation of E2F1 activity by acetylation
MA Martínez-Balbás et al.
EMBO JOURNAL (2000)
分享论文
